长沙信息网

首页 > 同城信息 / 正文

BRIEF-FDA grants priority review for Eagle Pharmace爆料台uticals' Ryanodex NDA for the treatment of ex

网络整理 2017-03-28 同城信息

March 27 (Reuters) - Eagle Pharmaceuticals Inc (EGRX.O)

* FDA grants priority review for Eagle Pharmaceuticals' Ryanodex NDA for the treatment of exertional heat stroke

* Eagle Pharmaceuticals Inc - PDUFA date of July 23, 2017

Source text for Eikon: Further company coverage: (EGRX.O)

Tags:BRIEF-FDA grants priority review for Eagle Pharmaceuticals' Ryanodex NDA for the

猜你喜欢

    SQL Error: select * from ***_ecms_article where id<>'3166' and (title like '%BRIEF-FDA grants priority review for Eagle Pharmaceuticals' Ryanodex NDA for the%') order by newstime desc limit 10
搜索
网站分类
标签列表